177 related articles for article (PubMed ID: 23616260)
1. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.
Sweeny L; Prince A; Patel N; Moore LS; Rosenthal EL; Hughley BB; Warram JM
Laryngoscope; 2016 Dec; 126(12):E387-E395. PubMed ID: 27576611
[TBL] [Abstract][Full Text] [Related]
3. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.
Day KE; Beck LN; Heath CH; Huang CC; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2013 Mar; 14(3):271-7. PubMed ID: 23298904
[TBL] [Abstract][Full Text] [Related]
4. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.
Korb ML; Hartman YE; Kovar J; Zinn KR; Bland KI; Rosenthal EL
J Surg Res; 2014 May; 188(1):119-28. PubMed ID: 24360117
[TBL] [Abstract][Full Text] [Related]
6. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
[TBL] [Abstract][Full Text] [Related]
7. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
[TBL] [Abstract][Full Text] [Related]
8. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
9. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
10. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
11. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
13. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
[TBL] [Abstract][Full Text] [Related]
14. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.
Morlandt AB; Moore LS; Johnson AO; Smith CM; Stevens TM; Warram JM; MacDougall M; Rosenthal EL; Amm HM
J Oral Maxillofac Surg; 2020 Oct; 78(10):1736-1747. PubMed ID: 32554066
[TBL] [Abstract][Full Text] [Related]
15. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
[TBL] [Abstract][Full Text] [Related]
16. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
[TBL] [Abstract][Full Text] [Related]
17. Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.
Houvast RD; Baart VM; Bhairosingh SS; Cordfunke RA; Chua JX; Vankemmelbeke M; Parsons T; Kuppen PJK; Durrant LG; Vahrmeijer AL; Sier CFM
Mol Imaging Biol; 2020 Dec; 22(6):1511-1522. PubMed ID: 32780212
[TBL] [Abstract][Full Text] [Related]
18. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
[No Abstract] [Full Text] [Related]
19. Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.
Cilliers C; Nessler I; Christodolu N; Thurber GM
Mol Pharm; 2017 May; 14(5):1623-1633. PubMed ID: 28294622
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]